Cambridge Capital Group – Startup Investor Profile

Cambridge Capital Group (CCG) is a private network of 60+ investors, business angels, and family offices. CCG invests in hi-tech businesses across the UK’s Golden Triangle and wider innovation centers. With a track record of investing in more than 70 live portfolio companies, CCG has backed tech start-ups in the region since 2000. The group has invested tens of millions of pounds, with successes like Bookham Technology and nCipher. Their investment check size ranges from £100,000 to £2 million for early-stage opportunities. CCG’s partnership and collaboration style involves co-investing in opportunities that interest individual members, fostering a collaborative environment. They support their investments by providing funding for growth capital, strategic initiatives, acquisitions, and shareholder liquidity, while willing to invest in a majority or minority capacity. The group has achieved multiple successful exits, including Swiftkey being sold to Microsoft and Cambridge CMOS Sensors to Austrian Microsystems.

Location: The Bradfield Centre, Unit 184

Country: United Kingdom of Great Britain and Northern Ireland

Investment Regions: EU, SA, SEA

Investment Stages: pre-seed, seed, series-a

Website: http://www.cambridgecapitalgroup.co.uk/

AI Reasoning: Search results (Tracxn page last updated Oct 18, 2025) show Cambridge Capital Group’s latest listed investment was in Cytochroma on Dec 16, 2021. That is over 3 years and 10 months before the assignment date, which exceeds 12 months, so classify as not-active. The invested startup found: Cytochroma.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.